Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions

Journal of Ginseng Research

Volumn 42, Issue 3, 2018, Pages 239-247

  Kim, Ki Hyun ^a   Lee, Dahae ^a   Lee, Hye Lim ^b   Kim, Chang Eop ^b   Jung, Kiwon ^c   Kang, Ki Sung ^b  

^a Sungkyunkwan University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c CHA University   (South Korea)

Author keywords

antioxidant; ginsenosides; neurodegenerative diseases; Panax ginseng

Indexed keywords

ALKALOID DERIVATIVE; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RG 2; GINSENOSIDE RG 3; GINSENOSIDE RH 2; PHENOL DERIVATIVE; POLYACETYLENE DERIVATIVE; POLYSACCHARIDE; SESQUITERPENE DERIVATIVE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHEMICAL STRUCTURE; CLASSIFICATION; DEGENERATIVE DISEASE; GINSENG; HUNTINGTON CHOREA; IMMUNOMODULATION; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 85018933403     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2017.03.011     Document Type: Review

References (113)

1. Helms, S., Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 9 (2004), 259–274.
2. Shin, B.K., Kwon, S.W., Park, J.H., Chemical diversity of ginseng saponins from Panax ginseng. J Ginseng Res 39 (2015), 287–298.
3. Kim, D.H., Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J Ginseng Res 36 (2012), 1–15.
4. Park, J.D., Rhee, D.K., Lee, Y.H., Biological activities and chemistry of saponins from Panax ginseng CA Meyer. Phytochem Rev 4 (2005), 159–175.
5. Liu, C.X., Xiao, P.G., Recent advances on ginseng research in China. J Ethnopharmacol 36 (1992), 27–38.
6. Wang, J., Li, S., Fan, Y., Chen, Y., Liu, D., Cheng, H., Gao, X., Zhou, Y., Anti-fatigue activity of the water-soluble polysaccharides isolated from Panax ginseng CA Meyer. J Ethnopharmacol 130 (2010), 421–423.
7. Lee, S.M., Bae, B.S., Park, H.W., Ahn, N.G., Cho, B.G., Cho, Y.L., Kwak, Y.S., Characterization of Korean Red Ginseng (Panax ginseng Meyer): history, preparation method, and chemical composition. J Ginseng Res 39 (2015), 384–391.
8. Han, M.S., Han, I.H., Lee, D., An, J.M., Kim, S.N., Shin, M.S., Yamabe, N., Hwang, G.S., Yoo, H.H., Choi, S.J., Beneficial effects of fermented black ginseng and its ginsenoside 20 (S)-Rg3 against cisplatin-induced nephrotoxicity in LLC-PK1 cells. J Ginseng Res 40 (2016), 135–140.
9. Park, J.Y., Choi, P., Kim, H.K., Kang, K.S., Ham, J., Increase in apoptotic effect of Panax ginseng by microwave processing in human prostate cancer cells: in vitro and in vivo studies. J Ginseng Res 40 (2016), 62–67.
10. Babiker, L.B., Gadkariem, E.A., Alashban, R.M., Aljohar, H.I., Investigation of stability of Korean ginseng in herbal drug product. Am J Appl Sci 11 (2014), 160–170.
11. Zhang, D., Yasuda, T., Yu, Y., Zheng, P., Kawabata, T., Ma, Y., Okada, S., Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation. Free Radic Biol Med 20 (1996), 145–150.
12. Yun, T.K., Choi, S.Y., Yun, H.Y., Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng?. J Korean Med Sci 16 (2001), S19–S27.
13. Joo, S.S., Won, T.J., Lee, D.I., Reciprocal activity of ginsenosides in the production of proinflammatory repertoire, and their potential roles in neuroprotection in vitro. Planta Med 71 (2005), 476–481.
14. Jung, C.H., Seog, H.M., Choi, I.W., Choi, H.D., Cho, H.Y., Effects of wild ginseng (Panax ginseng CA Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats. J Ethnopharmacol 98 (2005), 245–250.
15. Fang, Y., Shen, N., Chen, X., Beneficial changes in prostacyclin and thromboxane A2 induced by ginsenosides in myocardial infarction and reperfusion injury in dogs. Zhongguo Yao Li Xue Bao 7 (1986), 226–230.
16. Sakata, T., Etou, H., Fujimoto, K., Ockuma, K., Hayashi, T., Arichi, S., Central effects of ginsenosides on the feeding behavior and response to stress in rats. Korea–Japan Panax ginseng Symposium, 1987, 20–28.
17. Fujimoto, K., Sakata, T., Ishimaru, T., Etou, H., Ookuma, K., Kurokawa, M., Machidori, H., Attenuation of anorexia induced by heat or surgery during sustained administration of ginsenoside Rg1 into rat third ventricle. Psychopharmacology 99 (1989), 257–260.
18. Xie, J.T., McHendale, S., Yuan, C.S., Ginseng and diabetes. Am J Chin Med 33 (2005), 397–404.
19. Yang, G., Park, D., Lee, J., Song, B.S., Jeon, T.H., Kang, S.J., Jeon, J.H., Shin, S., Jeong, H.S., Lee, H.J., Suppressive effects of red ginseng preparations on SW480 colon cancer xenografts in mice. Food Sci Biotechnol 20 (2011), 1649–1653.
20. Cho, I.H., Effects of Panax ginseng in neurodegenerative diseases. J Ginseng Res, 36, 2012, 342.
21. Kang, S.W., Min, H.Y., Ginseng, the 'immunity boost': the effects of Panax ginseng on immune system. J Ginseng Res 36 (2012), 354–368.
22. Park, J., Recent studies on the chemical constituents of Korean ginseng (Panax ginseng CA Meyer). Korean J Ginseng Sci 20 (1996), 389–415.
23. Elyakov, G., Strigina, L., Uvarova, N., Vaskovsky, V., Dzizenko, A., Kochetkov, N., Glycosides from ginseng roots. Tetrahedron Lett 5 (1964), 3591–3597.
24. Shibata, S., Fujita, M., Itokawa, H., Tanaka, O., Ishii, T., Studies on the constituents of Japanese and Chinese crude drugs. XI. Panaxadiol, a sapogenin of ginseng roots. Chem Pharm Bull 11 (1963), 759–761.
25. Lu, J.M., Yao, Q., Chen, C., Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 7 (2009), 293–302.
26. Fuzzati, N., Analysis methods of ginsenosides. J Chromatogr B Analyt Technol Biomed Life Sci 812 (2004), 119–133.
27. Lee, S.M., Thermal conversion pathways of ginsenoside in red ginseng processing. Nat Prod Sci 20 (2014), 119–125.
28. Takahashi, M., Yoshikura, M., Studies on the components of Panax ginseng CA Meyer. V. On the structure of a new acetylene derivative “panaxynol” (3). Synthesis of 1,9-(cis)-heptadecadiene-4,6-diyn-3-ol. Yakugaku Zasshi 86 (1966), 1053–1056.
29. Kong, Y.H., Lee, Y.C., Choi, S.Y., Neuroprotective and anti-inflammatory effects of phenolic compounds in Panax ginseng CA Meyer. J Ginseng Res 33 (2009), 111–114.
30. Chung, I.M., Lim, J.J., Ahn, M.S., Jeong, H.N., An, T.J., Kim, S.H., Comparative phenolic compound profiles and antioxidative activity of the fruit, leaves, and roots of Korean ginseng (Panax ginseng Meyer) according to cultivation years. J Ginseng Res 40 (2016), 68–75.
31. Lee, H., Yoo, B., Byun, S., Differences in phenolic acids between Korean ginsengs and mountain ginsengs. Korean J Biotechnol Bioeng 15 (2000), 323–328.
32. Iwabuchi, H., Yoshikura, M., Kamisako, W., Studies on the sesquiterpenoids of Panax ginseng C. A. Meyer. II. Isolation and structure determination of ginsenol, a novel sesquiterpene alcohol. Chem Pharm Bull (Tokyo) 36 (1988), 2447–2451.
33. Richter, R., Basar, S., Koch, A., König, W.A., Three sesquiterpene hydrocarbons from the roots of Panax ginseng CA Meyer (Araliaceae). Phytochemistry 66 (2005), 2708–2713.
34. Wang, J.Y., Li, X.G., Yang, X.W., Ginsenine, a new alkaloid from the berry of Panax ginseng CA Meyer. J Asian Nat Prod Res 8 (2006), 605–608.
35. Konno, C., Murakami, M., Oshima, Y., Hikino, H., Isolation and hypoglycemic activity of panaxans Q, R, S, T and U, glycans of Panax ginseng roots. J Ethnopharmacol 14 (1985), 69–74.
36. Konno, C., Sugiyama, K., Kano, M., Takahashi, M., Hikino, H., Isolation and hypoglycaemic activity of panaxans A, B, C, D and E, glycans of Panax ginseng roots. Planta Med 50 (1984), 434–436.
37. Oshima, Y., Konno, C., Hikino, H., Isolation and hypoglycemic activity of panaxans I, J, K and L, glycans of Panax ginseng roots. J Ethnopharmacol 14 (1985), 255–259.
38. Tomoda, M., Takeda, K., Shimizu, N., Gonda, R., Ohara, N., Takada, K., Hirabayashi, K., Characterization of two acidic polysaccharides having immunological activities from the root of Panax ginseng. Biol Pharm Bull 16 (1993), 22–25.
39. Zhang, X., Yu, L., Bi, H.T., Li, X.H., Ni, W.H., Han, H., Li, N., Wang, B.Q., Zhou, Y.F., Tai, G.H., Total fractionation and characterization of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer. Carbohyd Polym 77 (2009), 544–552.
40. Fan, Y.Y., Sun, C.X., Gao, X.G., Wang, F., Li, X.Z., Kassim, R.M., Tai, G.H., Zhou, Y.F., Neuroprotective effects of ginseng pectin through the activation of ERK/MAPK and Akt survival signaling pathways. Mol Med Rep 5 (2012), 1185–1190.
41. Fan, Y.Y., Cheng, H.R., Liu, D., Zhang, X., Wang, B., Sun, L., Tai, G.H., Zhou, Y.F., The inhibitory effect of ginseng pectin on L-929 cell migration. Arch Pharm Res 33 (2010), 681–689.
42. Francis, P.T., Palmer, A.M., Snape, M., Wilcock, G.K., The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66 (1999), 137–147.
43. Tong, L.M., Fong, H., Huang, Y., Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives. Exp Mol Med, 47, 2015, e151.
44. Serrano-Pozo, A., Frosch, M.P., Masliah, E., Hyman, B.T., Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med, 1, 2011, a006189.
45. Musiek, E.S., Xiong, D.D., Holtzman, D.M., Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp Mol Med, 47, 2015, e148.
46. Ciechanover, A., Kwon, Y.T., Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med, 47, 2015, e147.
47. Bajda, M., Guzior, N., Ignasik, M., Malawska, B., Multi-target-directed ligands in Alzheimer's disease treatment. Curr Med Chem 18 (2011), 4949–4975.
48. Mancuso, C., Bates, T.E., Butterfield, D.A., Calafato, S., Cornelius, C., Lorenzo, A.D., Dinkova Kostova, A.T., Calabrese, V., Natural antioxidants in Alzheimer's disease. Expert Opin Investig Drugs 16 (2007), 1921–1931.
49. Zhao, B.S., Liu, Y., Gao, X.Y., Zhai, H.Q., Guo, J.Y., Wang, X.Y., Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signalling transduction factors in the NG108-15 murine neuroglial cell line. Molecules 19 (2014), 16925–16936.
50. Hwang, J.Y., Shim, J.S., Song, M.Y., Yim, S.V., Lee, S.E., Park, K.S., Proteomic analysis reveals that the protective effects of ginsenoside Rb1 are associated with the actin cytoskeleton in β-amyloid-treated neuronal cells. J Ginseng Res 40 (2016), 278–284.
51. Tan, X., Gu, J., Zhao, B., Wang, S., Yuan, J., Wang, C., Chen, J., Liu, J., Feng, L., Jia, X., Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats. J Ginseng Res 39 (2015), 116–124.
52. Zhang, Y., Pi, Z., Song, F., Liu, Z., Ginsenosides attenuate d-galactose-and AlCl 3-inducedspatial memory impairment by restoring the dysfunction of the neurotransmitter systems in the rat model of Alzheimer's disease. J Ethnopharmacol 194 (2016), 188–195.
53. Zhao, H., Li, Q., Li, Y., Long-term ginsenoside administration prevents memory loss in aged female C57BL/6J mice by modulating the redox status and up-regulating the plasticity-related proteins in hippocampus. Neuroscience 183 (2011), 189–202.
54. Zhao, H., Li, Q., Zhang, Z., Pei, X., Wang, J., Li, Y., Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus. Brain Res 1256 (2009), 111–122.
55. Hou, J., Xue, J., Lee, M., Yu, J., Sung, C., Long-term administration of ginsenoside Rh1 enhances learning and memory by promoting cell survival in the mouse hippocampus. Int J Mol Med 33 (2014), 234–240.
56. Chu, S., Gu, J., Feng, L., Liu, J., Zhang, M., Jia, X., Liu, M., Yao, D., Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses. Int Immunopharmacol 19 (2014), 317–326.
57. Kim, E.J., Jung, I.H., Van Le, T.K., Jeong, J.J., Kim, N.J., Kim, D.H., Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice. J Ethnopharmacol 146 (2013), 294–299.
58. Song, X.Y., Hu, J.F., Chu, S.F., Zhang, Z., Xu, S., Yuan, Y.H., Han, N., Liu, Y., Niu, F., He, X., Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats. Eur J Pharmacol 710 (2013), 29–38.
59. Heo, J.H., Lee, S.T., Chu, K., Oh, M.J., Park, H.J., Shim, J.Y., Kim, M., Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease. Nutr Neurosci 15 (2012), 278–282.
60. Wang, Y., Yang, G., Gong, J., Lu, F., Diao, Q., Sun, J., Zhang, K., Tian, J., Liu, J., Ginseng for Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials. Curr Top Med Chem 16 (2016), 529–536.
61. Hornykiewicz, O., Dopamine in the basal ganglia: its role and therapeutic implications (including the clinical use of L-DOPA). Br Med Bull 29 (1973), 172–178.
62. Hornykiewicz, O., How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago. Wien Klin Wochenschr 113 (2001), 855–862.
63. Mizuno, Y., Mori, H., Kondo, T., Parkinson's disease: from etiology to treatment. Int Med 34 (1995), 1045–1054.
64. Sherer, T., Betarbet, R., Greenamyre, J., Pathogenesis of Parkinson's disease. Curr Opin Investig Drugs 2 (2001), 657–662.
65. Bae, J.R., Lee, B.D., Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond. BMB Rep 48 (2015), 243–248.
66. Pollanen, M.S., Dickson, D.W., Bergeron, C., Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52 (1993), 183–191.
67. Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M., Ihara, Y., Lewy bodies are ubiquitinated. Acta Neuropathol 75 (1988), 345–353.
68. Chung, Y.C., Shin, W.H., Baek, J.Y., Cho, E.J., Baik, H.H., Kim, S.R., Won, S.Y., Jin, B.K., CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease. Exp Mol Med, 48, 2016, e205.
69. Zhu, B.T., CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease. Int J Mol Med 13 (2004), 343–354.
70. Fahn, S., Cohen, G., The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32 (1992), 804–812.
71. Fahn, S., Bressman, S.B., Should levodopa therapy for parkinsonism be started early or late? Evidence against early treatment. Can J Neurol Sci 11 (1984), 200–205.
72. Alam, Z.I., Daniel, S.E., Lees, A.J., Marsden, D.C., Jenner, P., Halliwell, B., A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 69 (1997), 1326–1329.
73. Diamond, S.G., Marchkham, C.H., Hoehn, M.M., McDowell, F.H., Muenter, M.D., Multi-center study of Parkinson mortality with early versus later dopa treatment. Ann Neurol 22 (1987), 8–12.
74. Parodi, J., Ormeño, D., Ochoa-de la Paz, L.D., Amyloid pore-channel hypothesis: effect of ethanol on aggregation state using frog oocytes for an Alzheimer's disease study. BMB Rep 48 (2015), 13–18.
75. Hu, S., Han, R., Mak, S., Han, Y., Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng CA Meyer) in SH-SY5Y cells. J Ethnopharmacol 135 (2011), 34–42.
76. Zhou, T., Zu, G., Zhang, X., Wang, X., Li, S., Gong, X., Liang, Z., Zhao, J., Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease. Neuropharmacology 101 (2016), 480–489.
77. Liu, Y., Zhang, R.Y., Zhao, J., Dong, Z., Feng, D.Y., Wu, R., Shi, M., Zhao, G., Ginsenoside Rd protects SH-SY5Y cells against 1-methyl-4-phenylpyridinium induced injury. Int J Mol Sci 16 (2015), 14395–14408.
78. Woodruff, T.M., Thundyil, J., Tang, S.C., Sobey, C.G., Taylor, S.M., Arumugam, T.V., Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener, 6, 2011, 11.
79. Dong, X., Zheng, L., Lu, S., Yang, Y., Neuroprotective effects of pretreatment of ginsenoside Rb1 on severe cerebral ischemia-induced injuries in aged mice: involvement of anti-oxidant signaling. Geriatr Gerontol Int 17 (2017), 338–345, 10.1111/ggi.12699.
80. Zhang, X., Shi, M., Bjoras, M., Wang, W., Zhang, G., Han, J., Liu, Z., Zhang, Y., Wang, B., Chen, J., et al. Ginsenoside Rd promotes glutamate clearance by up-regulating glial glutamate transporter GLT-1 via PI3K/AKT and ERK1/2 pathways. Front Pharmacol, 4, 2013, 152.
81. Zhang, Y., Zhou, L., Zhang, X., Bai, J., Shi, M., Zhao, G., Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia. Neurol Sci 33 (2012), 1125–1131.
82. Ye, R., Zhang, X., Kong, X., Han, J., Yang, Q., Zhang, Y., Chen, Y., Li, P., Liu, J., Shi, M., Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia. Neuroscience 178 (2011), 169–180.
83. Ye, R., Yang, Q., Kong, X., Han, J., Zhang, X., Zhang, Y., Li, P., Liu, J., Shi, M., Xiong, L., Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats. Neurochem Int 58 (2011), 391–398.
84. He, L., Chen, X., Zhou, M., Zhang, D., Yang, J., Yang, M., Zhou, D., Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study. Phytomedicine 18 (2011), 437–442.
85. Rub, U., Vonsattel, J.P.G., Heinsen, H., Korf, H.W., The neuropathology of Huntington's disease: classical findings, recent developments and correlation to functional neuroanatomy conclusions and outlook. Adv Anat Embryol Cell Biol 217 (2015), 1–46.
86. Saudou, F., Humbert, S., The biology of huntingtin. Neuron 89 (2016), 910–926.
87. Zuccato, C., Valenza, M., Cattaneo, E., Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev 90 (2010), 905–981.
88. Politis, M., Pavese, N., Tai, Y.F., Tabrizi, S.J., Barker, R.A., Piccini, P., Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain 131 (2008), 2860–2869.
89. Bates, G., Jones, L., Huntington's disease. 2002, Oxford University Press, Oxford CIT0001.
90. Rosenblatt, A., Neuropsychiatry of Huntington's disease. Dialogues Clin Neurosci 9 (2007), 191–197.
91. Gao, Y., Chu, S.F., Li, J.P., Zhang, Z., Yan, J.Q., Wen, Z.L., Xia, C.Y., Mou, Z., Wang, Z.Z., He, W.B., Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease. Acta Pharmacol Sin 36 (2015), 311–322.
92. Wu, J., Jeong, H.K., Bulin, S.E., Kwon, S.W., Park, J.H., Bezprozvanny, I., Ginsenosides protect striatal neurons in a cellular model of Huntington's disease. J Neurosci Res 87 (2009), 1904–1912.
93. Amor, S., Puentes, F., Baker, D., Van Der Valk, P., Inflammation in neurodegenerative diseases. Immunology 129 (2010), 154–169.
94. Kannappan, R., Gupta, S.C., Kim, J.H., Reuter, S., Aggarwal, B.B., Neuroprotection by spice-derived nutraceuticals: you are what you eat!. Mol Neurobiol 44 (2011), 142–159.
95. Marchetti, B., Abbracchio, M.P., To be or not to be (inflamed)—is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?. Trends Pharmacol Sci 26 (2005), 517–525.
96. Andersen, J.K., Oxidative stress in neurodegeneration: cause or consequence?. Nat Med 10 (2004), 18–25.
97. Son, J.H., Shim, J.H., Kim, K.H., Ha, J.Y., Han, J.Y., Neuronal autophagy and neurodegenerative diseases. Exp Mol Med 44 (2012), 89–98.
98. Ferrante, R.J., Shinobu, L.A., Schulz, J.B., Matthews, R.T., Thomas, C.E., Kowall, N.W., Gurney, M.E., Beal, M.F., Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol 42 (1997), 326–334.
99. Adibhatla, R.M., Hatcher, J.F., Dempsey, R.J., Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. Antioxid Redox Signal 5 (2003), 647–654.
100. Hall, N., Carney, J., Cheng, M., Butterfield, D., Ischemia/reperfusion-induced changes in membrane proteins and lipids of gerbil cortical synaptosomes. Neuroscience 64 (1995), 81–89.
101. Won, M.H., Kang, T.C., Jeon, G.S., Lee, J.C., Kim, D.Y., Choi, E.M., Lee, K.H., Do Choi, C., Chung, M.H., Cho, S.S., Immunohistochemical detection of oxidative DNA damage induced by ischemia–reperfusion insults in gerbil hippocampus in vivo. Brain Res 836 (1999), 70–78.
102. Dexter, D., Carter, C., Wells, F., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., Marsden, C.D., Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52 (1989), 381–389.
103. Hensley, K., Maidt, M.L., Yu, Z., Sang, H., Markesbery, W.R., Floyd, R.A., Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18 (1998), 8126–8132.
104. Butterfield, D.A., Castegna, A., Lauderback, C.M., Drake, J., Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23 (2002), 655–664.
105. Yang, H.Y., Lee, T.H., Antioxidant enzymes as redox-based biomarkers: a brief review. BMB Rep 48 (2015), 200–208.
106. Ye, M., Chung, H.S., Lee, C., Song, J.H., Shim, I., Kim, Y.S., Bae, H., Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice. Exp Mol Med, 48, 2016, e244.
107. Radad, K., Moldzio, R., Rausch, W.D., Ginsenosides and their CNS targets. CNS Neurosci Ther 17 (2011), 761–768.
108. Nguyen, C.T., Luong, T.T., Kim, G.L., Pyo, S., Rhee, D.K., Korean Red Ginseng inhibits apoptosis in neuroblastoma cells via estrogen receptor β-mediated phosphatidylinositol-3 kinase/Akt signaling. J Ginseng Res 39 (2015), 69–75.
109. Kim, S., Kim, M.S., Park, K., Kim, H.J., Jung, S.W., Nah, S.Y., Han, J.S., Chung, C., Hippocampus-dependent cognitive enhancement induced by systemic gintonin administration. J Ginseng Res 40 (2016), 55–61.
110. Kang, K.S., Ham, J., Kim, Y.J., Park, J.H., Cho, E.J., Yamabe, N., Heat-processed Panax ginseng and diabetic renal damage. J Ginseng Res 37 (2013), 379–388.
111. González-Burgos, E., Fernandez-Moriano, C., Gómez-Serranillos, M.P., Potential neuroprotective activity of ginseng in Parkinson's disease: a review. J Neuroimmune Pharmacol 10 (2015), 14–29.
112. Ong, W.Y., Farooqui, T., Koh, H.L., Farooqui, A.A., Ling, E.A., Protective effects of ginseng on neurological disorders. Front Aging Neurosci, 7, 2015, 129.
113. Li, N., Liu, Y., Li, W., Zhou, L., Li, Q., Wang, X., He, P., A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease. J Ginseng Res 40 (2016), 9–17.